Objectives: To determine the feasibility of delivering inhaled treprostinil during mechanical ventilation and spontaneous unassisted ventilation using the Tyvaso Inhalation System and the vibrating mesh nebulizer. We sought to compare differences in fine particle fraction, and absolute inhaled treprostinil mass delivered to neonatal, pediatric, and adult models affixed with a face mask, conventional, and high-frequency ventilation between Tyvaso Inhalation System and with different nebulizer locations between Tyvaso Inhalation System and vibrating mesh nebulizer. Design: Fine particle fraction was first determined via impaction with both the Tyvaso Inhalation System and vibrating mesh nebulizer. Next, a test lung configured with neonatal, pediatric, and adult mechanics and a filter to capture medication was attached to a realistic face model during spontaneous breathing or an endotracheal tube during conventional ventilation and high-frequency oscillator ventilator. Inhaled treprostinil was then nebulized with both the Tyvaso Inhalation System and vibrating mesh nebulizer, and the filter was analyzed via high-performance liquid chromatography. Testing was done in triplicate. Independent two-sample t tests were used to compare mean fine particle fraction and inhaled mass between devices. Analysis of variance with Tukey post hoc tests were used to compare within device differences. Setting: Academic children's hospital aerosol research laboratory. Measurements and Main Results: Fine particle fraction was not different between the Tyvaso Inhalation System and vibrating mesh nebulizer (0.78 +/- 0.04 vs 0.77 +/- 0.08, respectively; p = 0.79). The vibrating mesh nebulizer delivered the same or greater inhaled treprostinil than the Tyvaso Inhalation System in every simulated model and condition. When using the vibrating mesh nebulizer, delivery was highest when using high-frequency oscillator ventilator in the neonatal and pediatric models, and with the nebulizer in the distal position in the adult model. Conclusions: The vibrating mesh nebulizer is a suitable alternative to the Tyvaso Inhalation System for inhaled treprostinil delivery. Fine particle fraction is similar between devices, and vibrating mesh nebulizer delivery meets or exceeds delivery of the Tyvaso Inhalation System. Delivery for infants and children during high-frequency oscillator ventilator with the vibrating mesh nebulizer may result in higher than expected dosages. (C)2017The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2qc0F2V
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
As with many uncommon situations that are unique to critical illness, we cannot always rely on specialist consultation. Critical care prac...
-
Publication date: Available online 24 October 2016 Source: The Journal of Emergency Medicine Author(s): Abigail M. Schuh, Eileen J. Klein...
-
Editorial Radioiodine: 80 years and counting; the past, present, and future by Matthew D Ringel Thematic Review Radioiodine treatment: an h...
-
Big dreams to improve EMS with a windfall of funding for safety, health and wellness, research and leadership development from EMS via xlo...
-
Mitigate the effects a career in EMS can take to nurture your career longevity in EMS from EMS via xlomafota13 on Inoreader https://ift.tt...
-
Objectives: The Pediatric Acute Lung Injury Consensus Conference developed a pediatric specific definition for acute respiratory distress s...
-
Resuscitation is a System I Game... EMCrit by Scott Weingart . from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1Svu...
-
Injury from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2atuoga
-
Consent and Autonomy in the Genomics Era Abstract Purpose of Review Genomic tests offer increased opportunity for diagnosis, but their outpu...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου